Feb 13, 2020 / 06:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q3 FY '20 Earnings Conference Call of NATCO Pharma Limited hosted by Axis Capital Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Prakash Agarwal from Axis Capital. Thank you. And over to you, sir.
Prakash Agarwal - Axis Capital Limited, Research Division - Executive Director of Pharmaceuticals
Yes, thanks. I welcome you all on behalf of Axis Capital to the Q3 Fiscal '20 NATCO Conference Call, represented by senior management team, Mr. Rajeev Nannapaneni, Vice Chairman and Chief Executive Officer; and Mr. Rajesh Chebiyam, Vice President, Acquisitions, Institutional Investor Management and Corporate Communications.
Over to you, Rajesh.
Rajesh Chebiyam - NATCO Pharma Limited - VP of Acquisitions, Institutional Investor Management & Corporate Communications
Thank you, Prakash. Good morning, and welcome everyone to NATCO's conference call discussing our earnings results for
Q3 2020 Natco Pharma Ltd Earnings Call Transcript
Feb 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers